Molecular Neurobiology, 2024 · DOI: https://doi.org/10.1007/s12035-023-03616-0 · Published: September 6, 2023
This study investigates the role of the transcription factor Ets1 in spinal cord development and axon regeneration. Ets1 was found to be highly expressed during the embryonic period and decreased during spinal cord development. Knocking down Ets1 resulted in increased axonal growth of cultured spinal cord neurons, suggesting Ets1 inhibits axon regeneration. Ets1 regulates axon growth by controlling the expression of Lcn2, identifying Ets1 as a potential therapeutic target for axon regeneration in the central nervous system.
Ets1 may be a novel therapeutic target for axon regeneration in the central nervous system, offering potential for treating spinal cord injuries.
Knockdown of Ets1 may be a novel molecular therapy for axon regeneration in the central nervous system.
Future studies may explore the application of Ets1 antagomir as a potential treatment for central nervous system injury.